Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;51(5):1206-1217.
doi: 10.1002/eji.202048892. Epub 2021 Feb 17.

GFI1/HDAC1-axis differentially regulates immunosuppressive CD73 in human tumor-associated FOXP3+ Th17 and inflammation-linked Th17 cells

Affiliations
Free article

GFI1/HDAC1-axis differentially regulates immunosuppressive CD73 in human tumor-associated FOXP3+ Th17 and inflammation-linked Th17 cells

Dia Roy et al. Eur J Immunol. 2021 May.
Free article

Abstract

Plasticity between Th17 and Treg cells is regarded as a crucial determinant of tumor-associated immunosuppression. Classically Th17 cells mediate inflammatory responses through production of cytokine IL17. Recently, Th17 cells have also been shown to acquire suppressive phenotypes in tumor microenvironment. However, the mechanism by which they acquire such immunosuppressive properties is still elusive. Here, we report that in tumor microenvironment Th17 cell acquires immunosuppressive properties by expressing Treg lineage-specific transcription factor FOXP3 and ectonucleotidase CD73. We designate this cell as Th17reg cell and perceive that such immunosuppressive property is dependent on CD73. It was observed that in classical Th17 cell, GFI1 recruits HDAC1 to change the euchromatin into tightly-packed heterochromatin at the proximal-promoter region of CD73 to repress its expression. Whereas in Th17reg cells GFI1 cannot get access to CD73-promoter due to heterochromatin state at its binding site and, thus, cannot recruit HDAC1, failing to suppress the expression of CD73.

Keywords: CD73; FOXP3; GFI1; HDAC1; Th17.

PubMed Disclaimer

References

    1. Gajewski, T. F., Schreiber, H. and Fu, Y. -X. Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 2013. 14: 1014-1022.
    1. Guéry, L. and Hugues, S. Th17 cell plasticity and functions in cancer immunity. Biomed Res Int. 2015. 2015: 314620.
    1. Ye, J., Livergood, R. S. and Peng, G. The role and regulation of human Th17 cells in tumor immunity. Am. J. Pathol. 2013. 182: 10-20.
    1. Ivanov, I. I., Zhou, L. and Littman, D. R. Transcriptional regulation of Th17 cell differentiation. Semin. Immunol. 2007. 19: 409-417.
    1. He, S., Fei, M., Wu, Y., Zheng, D., Wan, D., Wang, L. and Li, D. Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients. Int. J. Mol. Sci. 2011. 12: 7424-7437.

Publication types

MeSH terms

LinkOut - more resources